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z-Thrombin, phorbol esters (PMA) and I,t-diacylglycerol (DAG), three activators of the amiloride-sensitive Na+/H+ exchange in human platelets, 
rapidly increase the intracellular pH and the level of phosphorylation of the Na’/H+ cxchangcr protein (NHEI). This stimulatory effect is sup 
pressed by staurosporine, a potent kinase inhibitor, and increased by okadaic acid. a potent inhibitor of phosphatase 1 and 2A. The modulations 
of NHEI phosphorylation by these factors correlate well with their cfTects on platelet pH. Thus. we conclude that in platelets (i) Na*/H+ exchange 
is mediated by NHE 1, and (ii) platelet activating agents stimulate NHEI via the modulation of the kinase/phosphatase equilibrium. 
Platelet; Thrombin: Na*/H+ exchanger; Phosphorylation: Okadaic acid 
1. INTRODUCTION 
An amiloride-sensitive Na+/H+ exchange [I] is pres- 
ent in the plasma membrane of blood platelets where it 
has been described to play a major role in the regulation 
of intracellular pH [2,3], cell volume [4] and platelet ac- 
tivation by cy-thrombin [5-S] and other agonists [9]. In- 
deed, treatment of human platelets by cr-thrombin 
[3,5-g] and by direct kinase C activators [7,8,10,1 l] 
such as phorbol esters or 1,2-diacylglycerol analogs, 
stimulate Naf/Hf exchange activity within seconds. 
Recently, using a specific polyclonal antibody [12], we 
demonstrated in CCL39 fibroblasts [ 121 and A431 
epithelial cells [12] that Na+/H+ exchange is achieved 
by a phosphorylated transmembrane glycoprotein of 
110 kDa referred to as NHEl (Na+/H’ exchanger 1) 
[12,13]. In GO-arrested fibroblasts, the stimulation of 
the Na’/H+ exchange activity by either mitogens (EGF, 
cr-thrombin, serum) [12], kinase C activator (phorbol 
esters) [ 121 or phosphatase 2A and 1 inhibitor (okadaic 
acid) [14] is associated with a parallel increase in the 
level of phosphorylation of NHEl, suggesting that 
phosphorylation of NHEl triggers Na+/H” exchange 
activation. 
In the present report, using the anti-NHEl polyclonal 
antibody mentioned above, we now demonstrate that 
NHEl is present in human blood platelets and that its 
level of phosphorylation in these cells parallels the 
modulation of the Na+/H’ exchange activity by pla- 
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telet activators (cr-thrombin and kinase C activators), 
kinase inhibitor (staurosporine) and phosphatase 1 and 
2A inhibitor (okadaic acid). 
2. MATERIALS AND METHODS 
[-‘*P]Orthophosphate (10 mCi/ml) was from Amersham. Albumin 
(bovine, essentially fatty acid-free from fractiun V), sn-1,2-dioctano- 
yl-glycerol (DAG), apyrase, prostaglandin El and phorbol lt-myris- 
tate 13-acetate (PMA) were obtained from Sigma. Staurosporine was 
from Calbiochem and the inhibitor R59022 from Janssen. Protein-A 
sepharose &MB was from Pharmacia and the detergent Nikko1 
BL-8SY (octo-ethyleneglycol mono-rl-dodecyl-ether) from Nikko 
Chemicals (Japan). Highly purified human n-thrombin was generous- 
ly provided by Dr J.W. Fenton II (New York State Department of 
Health, Albany, NY) and okadaic acid by Dr P. Cohen (Department 
of Biochemistry, University of Dundee, Dundce) and Y. Tsukitani 
(Fugisawa Chemicals, Tokyo). 
2.2. Platelet pvparoriotl 
Venous blood was drawn from healthy human volunteers, and an- 
ticoagulated with acid-citrate-dextrose (65 mM citric acid, 1 I mM 
glucose and 85 mM trisodium citrate) at a volume ratio of 6:l 
(blood:anlicoagulant), platelet-rich plasma was obtained by cen- 
trifugation at I20 x g for 10 min and had a pH 6.5. Then this plasma 
was supplemented with prostaglandin El (2.8 PM) and apyrase (2 
U/ml) and centrifuged at 1000 x g for 10 min. The platelets were 
resuspended (nhont l-7.x IO’/ml) in an isotonic medium A (140 mM 
NaCI, 5 mM KCI, 10 mM glucose, 20mM HEPES, pH 6.8,O.S mg/ml 
albumin and apyrase) and gel-filtered through a Scpharose 2B column 
(10 x 0.76 cm) (11,151. 
Gel-filtered platelets (I -2 x 109/ml) were incubated for 90 min in 
medium A containing 500 &i/ml [‘*P]ortl~opl~ospllote and gcl- 
fillcrcd again through a scpharosc 2B column. Then, just prior to 
stimulation with agonists, the pH of [he assay media was increased to 
7.2 with HEPES. After 5 min stimulation at 37% with agonists, cells 
wcrc immcdiatcly frozen in liquid nitrogen. 
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2.4. lmmut~oprecipi~a~ion of NHEl and elecfrophoreiic analysis 
IO” frozen platelets in buffer A (pH 7.2) were mixed with an equal 
volume of ice-cold buffer B (1% Nikkol. 50 mM HEPES-NaOH (pH 
7.4). 150 mM NaCI, 3 mM KCI, 20 mM sodium pyrophosphate, 10 
mM ATP, 5 mM EDTA, 1 mM phenylmethylsulfonyl fluoride 
(PMSF), I mM o-phenantroline, 1 rnM iodoacetamide), sonicated for 
40 s. left on ice for 15 min, and then centrifuged for 15 min at 
100 OOOxg. An aliquot of the supernatant (C) was kept for further 
electrophoretic analysis. The supernatants were adsorbed to protein 
A-sepharose 6-MB beads for I h and then incubated for 2 h at 4°C 
with affinity-purified RP-C28 antibodies [l2]. A 50% suspension of 
protein A sepharose beads (SOpI) (previously incubated with a Nikko1 
extract of Na’/H+ antiporter deficient mutant PSI20 [I61 was added, 
and the mixture was incubated for I h at 4°C in a rotating shaker. The 
beads were then washed 6 times with buffer A containing 1% Nikko1 
and 1 m&ml bovine serum albumin. lmmunoprecipitated proteins 
and aliquots of the supernatants (C) were solubilized by boiling in 
Laemmli sample buffer. Samples were analysed by SDS-PAGE elec- 
trophoresis on 7.5070 polyacrylamide gels under reducing conditions. 
Molecular weight markers were from Sigma: Phosphorylase b (97.4 
kDa); Bovine albumin (66 kDa); Egg albumin (45 kDa); Pepsin (34 
kDa); Trypsinogen (24 kDa). Phosphoproteins were visualized by 
autoradiography. 
3. RESULTS AND DISCUSSION 
3.1. NHEI is present in human blood platelets 
The presence of the amiloride-sensitive Na*/H+ ex- 
changer (NHEl) in Human blood platelets was in- 
vestigated using the immunopurified rabbit polyclonal 
anti-human NHEl antibody RPc-28 [12]. This antibody 
was previously demonstrated to be able to detect 
phosphorylated NHEI in other cell types [12]. Thus, 
platelets were labeled with [32P]orthophosphate, sotu- 
bilized with 1% detergent (Nikkol) solution, and the 
presence of NHEl detected by immunoprecipitation 
with RPc-28 antibody. The analysis of immunopreci- 
pitated phosphoproteins by SDS-PAGE and autoradio- 
graphy revealed a single phosphorylated protein with an 
apparent molecular weight of 105-I 10 kDa (Figs. 1 and 
3), a size similar to that detected in fibroblasts and 
epithelial cells [12]. This molecular weight and the ex- 
Fig. I. Effect of phorbol cstcr (PMA) rr-thrombin and staurosporinc 
on the phosphorylation of NHEl in human plntclcts. IO” ‘*P-labeled 
intact platclcts wcrc trcatcd (0 dcnotcs non-trcatcd pln~clc~s) for 5 milt 
with I00 nM PMA or I WIIII n~thrombin, with or without B prctrcnt. 
tllcllt with 100 nM stouroaporinc for 20 s. Cells wcrc Ihcn lytcd with 
1% Nikkol, iuid NHEI was immuttoprccipit;ttcd with the anti.NHEl 
antibody KP-~28 from the dctcrgcnt.cxtractcd proteins. lm- 
munoprccipitatcd NHEI was analyscd by SDS-PAGE id 
auloradiopraphy. Na’/H ’ -* ittdisatrs itnnrutioprcripitatcd NH51. 
treme specificity of RP-c28 antibodies for NHEl [12], 
led us to conclude that NHEl is present in human 
platelets. 
3.2. NHEI is phosphorylated in response to platelet 
activating agents 
The next objective of this study was to assess the ef- 
fect of platelet-activating agents on the phosphoryla- 
tion of NHEl. Unactivated 32P-labeled platelets con- 
tain weakly phosphorylated NHEl (Fig. 1) as well as 
weakly phosphorylated P47 protein (or pleckstrin) (Fig. 
2) [17,18]. P47 is a major and specific substrate for 
kinase C in platelets [18] which is easily detectable 
among total phosphoproteins (Figs. 2 and 4). When 
added for 5 min to these ‘resting’ platelets, in a concen- 
tration range that is known to produce a maximum ac- 
tivation of Na+/H+ exchange, cY-thrombin (1 U/ml) in- 
duces a marked increase in the level of phosphorylation 
of NHEl (Fig. 1) and of P47 proteins (Fig. 2). This 
phosphorylation of NHEl occurs within seconds 
following stimulation (We clearly observed PMA- 
enhanced phosphorylation within 20 s, data not 
shown), in a time-dependent manner which correlates 
well with an increase in intracellular pH [l 1] as 
previously reported [3,5-71. In many reports it is sug- 
gested that this cy-thrombin-dependent activation of the 
platelet Na+/H* exchange is mediated via G-protein- 
MW 
Wd 
45 
34 
Fig. 2, Effect of phorbol c$tcr (PMA), a-thrombin and stuurosporinc 
on the phosphorylatioti of fofal dctcrgcnt (I% NikkoI)-cstrartcd pro. 
tcins. I~la~clcls wcrc trcatcd as dcscribcd in Fig. I I Cells wcrc then Iys. 
cd with I Yo Nikko1 itttd aliquots of dcwrgcm-cxlrncicd probns wcrc 
nnalyscd by SDS-PACiE and autoradiography. l’47+ indicetcs I’47 
protciir (plcckntrin), the major substrntc of protcitt kinasc C. 
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Fig. 3. Effect of phorbol ester (PIMA), I,t-diacylglycerol (DAG), 
Janssen inhibitor R59022 and okadaic acid on the phosphorylation of 
NHEl. 10s ‘“P-labeled intact platelets were treated (0 denotes non- 
treated platelets) for 5 min with 100 nM PMA, 10 NM DAG, 1 ,rM 
okadaic or with a combination of 100 nM PMA and I pM okadaic 
acid, 10 PM DAG and IO pM inhibhor R59022. NHEl im- 
munoprecipitation was performed as described in Fig. 1. Na + /H a -+ 
indicates immunoprecipitated NHEI. 
coupled receptors and subsequent protein kinase C ac- 
tivation [8,11]. Indeed, phorbol esters (PMA) [7,1 I] 
and 1 ,Zdiacylglycerol analogs (DAG) [7,10,11] have 
been reported to be potent activators of the Na+/H+ ex- 
change in human platelets. In Fig. 1 and Fig. 3, we now 
demonstrate that PMA and DAG both stimulate NHEl 
and P47 phosphorylation to a similar extent to that 
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Fig. 4, Effect of phorbol cstcr (PMA), 1,2-diacylylyccroi analog 
(DA(;), inhibitor K59022 and okadnic acid on [hc phosphorglnlion of 
total dctcrycnt (I% Nikko])-cstrnctcd proteins. Pla~clc~s wcrc Ircntcd 
as dcscribcd in Fig. 3 and prorcins ;~~lyscd as dcscribcd in Fig. 2. 
P47-+ indicatca 1’47 protein (plctkslrin), ~hc major substrate of pro. 
lcill kinasc C’. 
elicited by cy-thrombin. The effect of DAG appears to 
be strongly increased in the presence of a diacylglycerol 
kinase inhibitor (R59022) [19] (Figs. 3 and 4). Indeed, 
this addition probably avoids the rapid conversion of 
DAG to non-active forms [19]. Conversely, stauro- 
sporine, a potent but non-specific inhibitor of kinase C 
[20] which has been described to curtail DAG and 
PMA-induced Na+/H+ exchange activation in platelets 
[ill, completely abolishes PMA and cr-thrombin- 
stimulated phosphorylation of NHEl (Fig. 1) and of 
P47 proteins (Fig. 3) 1211. 
In view of the results described above, we conclude 
that NHEl and P47 protein phosphorylation seem to be 
stimulated and inhibited in the same manner. This 
analogy suggests that protein kinase C is involved in the 
regulation of the Na+/H+ exchange in human platelets 
via direct or indirect stimulation of NHEl phosphoryla- 
tion. 
3.3. NffEl is phosphorylated in response to okadaic 
acid, a phosphatase inhibitor 
Like most phosphoproteins, the level of phosphory- 
lation of the exchanger probably results from a dyna- 
mic equilibrium between kinase and phosphatase ac- 
tivities. Indeed, okadaic acid, a potent inhibitor of pro- 
tein phosphatase 1 and 2A [22], activates the Na+/H+ 
exchange in fibroblast [ 151 and in human platelets [ 1 I]. 
As shown in Fig. 3, alone, this inhibitor weakly 
stimulates the phosphorylation of NHEl in platelets. 
This effect of okadaic acid on intact platelets, is pro- 
bably due to the fact that the toxin produces a large in- 
crease in the total phosphorylation of cellular protein 
[22] (Fig. 4), presumably by inhibiting phosphatases 
PPl and PPZA in vivo. This also suggests that the 
kinase(s) which phosphorylates NHEl is partly active in 
the absence of platelet activating agents. As the toxin 
also strongly increases the NHEl phosphorylation in- 
duced by PMA (Fig. 3), it is tempting to suggest that 
okadaic acid acts at two levels, on NHEl itself and on 
the kinase activating cascade mimicking platelet ac- 
tivating agents [23]. 
In conclusion, the ability of platelet activating agents 
as well as okadaic acid to stimulate phosphorylation of 
NHEl, concomitant with the activation of Na’/H+ ex- 
change, strongly supports the conclusion that NHEl 
phosphorylation is likely to be the mechanism that con- 
trols the amiloride-sensitive Na+/H+ exchange in 
human platelets. 
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